{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T09:06:48Z","timestamp":1784020008778,"version":"3.55.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:00:00Z","timestamp":1778198400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:00:00Z","timestamp":1778198400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100022874","name":"Agendia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100022874","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s10549-026-07982-w","type":"journal-article","created":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T09:41:26Z","timestamp":1778233286000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Whole transcriptome analysis reveals MammaPrint and BluePrint-associated gene expression patterns with early lymph node metastasis in early-stage breast cancer"],"prefix":"10.1007","volume":"217","author":[{"given":"Faisal","family":"Fa\u2019ak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josien","family":"Haan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Chmielewski-Stivers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Menicucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Audeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phyu Phyu","family":"Soe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanna","family":"Logman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soojin","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"D\u2019Abreo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan","family":"Baum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas K.","family":"Marks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the FLEX Investigators\u2019 Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,8]]},"reference":[{"key":"7982_CR1","doi-asserted-by":"publisher","first-page":"e31","DOI":"10.1200\/EDBK_159077","volume":"35","author":"D Ribnikar","year":"2016","unstructured":"Ribnikar D, Cardoso F (2016) Tailoring Chemotherapy in Early-Stage Breast Cancer: Based on Tumor Biology or Tumor Burden? Am Soc Clin Oncol Educ Book 35:e31\u2013e38. https:\/\/doi.org\/10.1200\/EDBK_159077","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"7982_CR2","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1093\/ANNONC\/MDP322","volume":"20","author":"A Goldhirsch","year":"2009","unstructured":"Goldhirsch A, Ingle JN, Gelber RD, Coates AS, Th\u00fcrlimann B, Senn HJ (2009) Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009. Ann Oncol 20:1319\u20131329. https:\/\/doi.org\/10.1093\/ANNONC\/MDP322","journal-title":"Ann Oncol"},{"key":"7982_CR3","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1002\/1097-0142(19890101)63:1<181::aid-cncr2820630129>3.0.co;2-h","volume":"63","author":"CL Carter","year":"1989","unstructured":"Carter CL, Allen C, Henson DE (1989) Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer 63:181\u2013187. https:\/\/doi.org\/10.1002\/1097-0142(19890101)63:1%3C181::aid-cncr2820630129%3E3.0.co;2-h","journal-title":"Cancer"},{"key":"7982_CR4","doi-asserted-by":"publisher","first-page":"6368","DOI":"10.1158\/1078-0432.CCR-19-0075","volume":"25","author":"L Dihge","year":"2019","unstructured":"Dihge L, Vallon-Christersson J, Hegardt C, Saal LH, H\u00e4kkinen J, Larsson C, Ehinger A, Loman N, Malmberg M, Bendahl PO, Borg \u00c5, Staaf J, Ryd\u00e9n L (2019) Prediction of Lymph Node Metastasis in Breast Cancer by Gene Expression and Clinicopathological Models: Development and Validation within a Population-Based Cohort. Clin Cancer Res 25:6368\u20136381. https:\/\/doi.org\/10.1158\/1078-0432.CCR-19-0075","journal-title":"Clin Cancer Res"},{"key":"7982_CR5","doi-asserted-by":"publisher","first-page":"28","DOI":"10.3322\/CANJCLIN.47.1.28","volume":"47","author":"WL Donegan","year":"1997","unstructured":"Donegan WL (1997) Tumor-related prognostic factors for breast cancer. CA Cancer J Clin 47:28\u201351. https:\/\/doi.org\/10.3322\/CANJCLIN.47.1.28","journal-title":"CA Cancer J Clin"},{"key":"7982_CR6","doi-asserted-by":"publisher","first-page":"7703","DOI":"10.1200\/JCO.2005.08.001","volume":"23","author":"GH Lyman","year":"2005","unstructured":"Lyman GH, Giuliano AE, Somerfield MR, Benson AB, Bodurka DC, Burstein HJ, Cochran AJ, Cody HS, Edge SB, Galper S, Hayman JA, Kim TY, Perkins CL, Podoloff DA, Sivasubramaniam VH, Turner RR, Wahl R, Weaver DL, Wolff AC, Winer EP (2005) American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol 23:7703\u20137720. https:\/\/doi.org\/10.1200\/JCO.2005.08.001","journal-title":"J Clin Oncol"},{"key":"7982_CR7","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1097\/00000658-199911000-00012","volume":"230","author":"C Gajdos","year":"1999","unstructured":"Gajdos C, Tartter PI, Bleiweiss IJ (1999) Lymphatic invasion, tumor size, and age are independent predictors of axillary lymph node metastases in women with T1 breast cancers. Ann Surg 230:692\u2013696. https:\/\/doi.org\/10.1097\/00000658-199911000-00012","journal-title":"Ann Surg"},{"key":"7982_CR8","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1126\/SCIENCE.1228522","volume":"339","author":"M Yu","year":"2013","unstructured":"Yu M, Bardia A, Wittner BS, Stott SL, Smas ME, Ting DT, Isakoff SJ, Ciciliano JC, Wells MN, Shah AM, Concannon KF, Donaldson MC, Sequist LV, Brachtel E, Sgroi D, Baselga J, Ramaswamy S, Toner M, Haber DA, Maheswaran S (2013) Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition. Science 339:580\u2013584. https:\/\/doi.org\/10.1126\/SCIENCE.1228522","journal-title":"Science"},{"key":"7982_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S13059-015-0819-6\/FIGURES\/8","volume":"16","author":"C Cui","year":"2015","unstructured":"Cui C, Gan Y, Gu L, Wilson J, Liu Z, Zhang B, Deng D (2015) P16-specific DNA methylation by engineered zinc finger methyltransferase inactivates gene transcription and promotes cancer metastasis. Genome Biol 16:1\u201312. https:\/\/doi.org\/10.1186\/S13059-015-0819-6\/FIGURES\/8","journal-title":"Genome Biol"},{"key":"7982_CR10","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1023\/B:BREA.0000041579.51902.89","volume":"87","author":"L Espa\u00f1a","year":"2004","unstructured":"Espa\u00f1a L, Fern\u00e1ndez Y, Rubio N, Torregrosa A, Blanco J, Sierra A (2004) Overexpression of Bcl-xL in human breast cancer cells enhances organ-selective lymph node metastasis. Breast Cancer Res Treat 87:33\u201344. https:\/\/doi.org\/10.1023\/B:BREA.0000041579.51902.89","journal-title":"Breast Cancer Res Treat"},{"key":"7982_CR11","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1186\/1471-2407-12-562","volume":"12","author":"W Siggelkow","year":"2012","unstructured":"Siggelkow W, Boehm D, Gebhard S, Battista M, Sicking I, Lebrecht A, Solbach C, Hellwig B, Rahnenf\u00fchrer J, Koelbl H, Gehrmann M, Marchan R, Cadenas C, Hengstler JG, Schmidt M (2012) Expression of aurora kinase A is associated with metastasis-free survival in node-negative breast cancer patients. BMC Cancer 12:562. https:\/\/doi.org\/10.1186\/1471-2407-12-562","journal-title":"BMC Cancer"},{"key":"7982_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S13058-016-0781-6\/FIGURES\/5","volume":"18","author":"AIJ Young","year":"2016","unstructured":"Young AIJ, Law AMK, Castillo L, Chong S, Cullen HD, Koehler M, Herzog S, Brummer T, Lee EF, Fairlie WD, Lucas MC, Herrmann D, Allam A, Timpson P, Watkins DN, Millar EKA, O\u2019Toole SA, Gallego-Ortega D, Ormandy CJ, Oakes SR (2016) MCL-1 inhibition provides a new way to suppress breast cancer metastasis and increase sensitivity to dasatinib. Breast Cancer Res 18:1\u201315. https:\/\/doi.org\/10.1186\/S13058-016-0781-6\/FIGURES\/5","journal-title":"Breast Cancer Res"},{"key":"7982_CR13","doi-asserted-by":"publisher","first-page":"2310","DOI":"10.1172\/JCI97449","volume":"128","author":"L Bao","year":"2018","unstructured":"Bao L, Qian Z, Lyng MB, Wang L, Yu Y, Wang T, Zhang X, Yang H, Br\u00fcnner N, Wang J, Ditzel HJ (2018) Coexisting genomic aberrations associated with lymph node metastasis in breast cancer. J Clin Invest 128:2310\u20132324. https:\/\/doi.org\/10.1172\/JCI97449","journal-title":"J Clin Invest"},{"key":"7982_CR14","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/NATURE15756","volume":"527","author":"A Hoshino","year":"2015","unstructured":"Hoshino A, Costa-Silva B, Shen TL, Rodrigues G, Hashimoto A, Tesic Mark M, Molina H, Kohsaka S, Di Giannatale A, Ceder S, Singh S, Williams C, Soplop N, Uryu K, Pharmer L, King T, Bojmar L, Davies AE, Ararso Y, Zhang T, Zhang H, Hernandez J, Weiss JM, Dumont-Cole VD, Kramer K, Wexler LH, Narendran A, Schwartz GK, Healey JH, Sandstrom P, J\u00f8rgen Labori K, Kure EH, Grandgenett PM, Hollingsworth MA, De Sousa M, Kaur S, Jain M, Mallya K, Batra SK, Jarnagin WR, Brady MS, Fodstad O, Muller V, Pantel K, Minn AJ, Bissell MJ, Garcia BA, Kang Y, Rajasekhar VK, Ghajar CM, Matei I, Peinado H, Bromberg J, Lyden D (2015) Tumour exosome integrins determine organotropic metastasis. Nature 527:329\u2013335. https:\/\/doi.org\/10.1038\/NATURE15756","journal-title":"Nature"},{"key":"7982_CR15","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1200\/JCO.2024.42.16_SUPPL.506","volume":"42","author":"EF Cobain","year":"2024","unstructured":"Cobain EF, Pusztai L, Graham CL, Whitworth PW, Beitsch PD, Osborne CRC, Rahman RL, Johnson NM, Brufsky A, Mahtani RL, Gadi V, Hoskins K, Linden HM, Mukhtar RA, Esserman L, Haan J, Quinn K, Menicucci A, Audeh MW, O\u2019Shaughnessy J (2024) Elucidating the immune active state of HR+HER2- MammaPrint High 2 early breast cancer. J Clin Oncol 42:506\u2013506. https:\/\/doi.org\/10.1200\/JCO.2024.42.16_SUPPL.506","journal-title":"J Clin Oncol"},{"key":"7982_CR16","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1200\/JCO.2024.42.16_SUPPL.511","volume":"42","author":"J O\u2019Shaughnessy","year":"2024","unstructured":"O\u2019Shaughnessy J, Graham CL, Whitworth P, Beitsch PD, Osborne CRC, Layeequr Rahman R, Brown EA, Gold LP, Johnson NM, Brufsky A, Ramaswamy H, Stivers N, Menicucci A, Audeh MW (2024) Association of MammaPrint index and 3-year outcome of patients with HR+HER2- early-stage breast cancer treated with chemotherapy with or without anthracycline. J Clin Oncol 42:511\u2013511. https:\/\/doi.org\/10.1200\/JCO.2024.42.16_SUPPL.511","journal-title":"J Clin Oncol"},{"key":"7982_CR17","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1056\/NEJMOA1602253","volume":"375","author":"F Cardoso","year":"2016","unstructured":"Cardoso F, van\u2019t Veer LJ, Bogaerts J, Slaets L, Viale G, Delaloge S, Pierga J-Y, Brain E, Causeret S, DeLorenzi M, Glas AM, Golfinopoulos V, Goulioti T, Knox S, Matos E, Meulemans B, Neijenhuis PA, Nitz U, Passalacqua R, Ravdin P, Rubio IT, Saghatchian M, Smilde TJ, Sotiriou C, Stork L, Straehle C, Thomas G, Thompson AM, van der Hoeven JM, Vuylsteke P, Bernards R, Tryfonidis K, Rutgers E, Piccart M (2016) 70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer. N Engl J Med 375:717\u2013729. https:\/\/doi.org\/10.1056\/NEJMOA1602253","journal-title":"N Engl J Med"},{"key":"7982_CR18","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/S10549-011-1683-Z","volume":"133","author":"O Krijgsman","year":"2012","unstructured":"Krijgsman O, Roepman P, Zwart W, Carroll JS, Tian S, De Snoo FA, Bender RA, Bernards R, Glas AM (2012) A diagnostic gene profile for molecular subtyping of breast cancer associated with treatment response. Breast Cancer Res Treat 133:37\u201347. https:\/\/doi.org\/10.1007\/S10549-011-1683-Z","journal-title":"Breast Cancer Res Treat"},{"key":"7982_CR19","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1038\/415530A","volume":"415","author":"LJ Van\u2019t Veer","year":"2002","unstructured":"Van\u2019t Veer LJ, Dai H, Van de Vijver MJ, He YD, Hart AAM, Mao M, Peterse HL, Van Der Kooy K, Marton MJ, Witteveen AT, Schreiber GJ, Kerkhoven RM, Roberts C, Linsley PS, Bernards R, Friend SH (2002) Gene expression profiling predicts clinical outcome of breast cancer. Nature 415:530\u2013536. https:\/\/doi.org\/10.1038\/415530A","journal-title":"Nature"},{"key":"7982_CR20","doi-asserted-by":"publisher","unstructured":"Smyth GK (2005) limma: Linear Models for Microarray Data. Bioinf Comput Biology Solutions Using R Bioconductor 397\u2013420. https:\/\/doi.org\/10.1007\/0-387-29362-0_23","DOI":"10.1007\/0-387-29362-0_23"},{"key":"7982_CR21","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/J.2517-6161.1995.TB02031.X","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y (1995) Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. J Roy Stat Soc: Ser B (Methodol) 57:289\u2013300. https:\/\/doi.org\/10.1111\/J.2517-6161.1995.TB02031.X","journal-title":"J Roy Stat Soc: Ser B (Methodol)"},{"key":"7982_CR22","doi-asserted-by":"publisher","unstructured":"Sergushichev AA (2016) An algorithm for fast preranked gene set enrichment analysis using cumulative statistic calculation. bioRxiv 060012. https:\/\/doi.org\/10.1101\/060012","DOI":"10.1101\/060012"},{"key":"7982_CR23","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/J.CELS.2015.12.004","volume":"1","author":"A Liberzon","year":"2015","unstructured":"Liberzon A, Birger C, Thorvaldsd\u00f3ttir H, Ghandi M, Mesirov JP, Tamayo P (2015) The Molecular Signatures Database (MSigDB) hallmark gene set collection. Cell Syst 1:417. https:\/\/doi.org\/10.1016\/J.CELS.2015.12.004","journal-title":"Cell Syst"},{"key":"7982_CR24","doi-asserted-by":"publisher","unstructured":"Aran D, Hu Z, Butte AJ (2017) xCell: digitally portraying the tissue cellular heterogeneity landscape. Genome Biol 18. https:\/\/doi.org\/10.1186\/S13059-017-1349-1","DOI":"10.1186\/S13059-017-1349-1"},{"key":"7982_CR25","doi-asserted-by":"publisher","unstructured":"Racle J, de Jonge K, Baumgaertner P, Speiser DE, Gfeller D (2017) Simultaneous enumeration of cancer and immune cell types from bulk tumor gene expression data. Elife 6. https:\/\/doi.org\/10.7554\/ELIFE.26476","DOI":"10.7554\/ELIFE.26476"},{"key":"7982_CR26","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1093\/ANNONC\/MDU450","volume":"26","author":"R Salgado","year":"2015","unstructured":"Salgado R, Denkert C, Demaria S, Sirtaine N, Klauschen F, Pruneri G, Wienert S, Van den Eynden G, Baehner FL, Penault-Llorca F, Perez EA, Thompson EA, Symmans WF, Richardson AL, Brock J, Criscitiello C, Bailey H, Ignatiadis M, Floris G, Sparano J, Kos Z, Nielsen T, Rimm DL, Allison KH, Reis-Filho JS, Loibl S, Sotiriou C, Viale G, Badve S, Adams S, Willard-Gallo K, Loi S (2015) The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014. Ann Oncol 26:259\u2013271. https:\/\/doi.org\/10.1093\/ANNONC\/MDU450","journal-title":"Ann Oncol"},{"key":"7982_CR27","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1097\/PAI.0000000000000041","volume":"23","author":"JS Cho","year":"2015","unstructured":"Cho JS, Park MH, Lee JS, Yoon JH (2015) Reduced MUC4 expression is a late event in breast carcinogenesis and is correlated with increased infiltration of immune cells as well as promoter hypermethylation in invasive breast carcinoma. Appl Immunohistochem Mol Morphol 23:44\u201353. https:\/\/doi.org\/10.1097\/PAI.0000000000000041","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"7982_CR28","doi-asserted-by":"publisher","first-page":"14147","DOI":"10.18632\/ONCOTARGET.13122","volume":"8","author":"P Xia","year":"2017","unstructured":"Xia P, Choi AH, Deng Z, Yang Y, Zhao J, Wang Y, Hardwidge PR, Zhu G (2017) Cell membrane-anchored MUC4 promotes tumorigenicity in epithelial carcinomas. Oncotarget 8:14147. https:\/\/doi.org\/10.18632\/ONCOTARGET.13122","journal-title":"Oncotarget"},{"key":"7982_CR29","doi-asserted-by":"publisher","unstructured":"Mo Chua, Gao L, Zhu X, fei, Wei K, lai, Zeng Jjing, Chen G, Feng Z (2017) bo The clinicopathological significance of UBE2C in breast cancer: a study based on immunohistochemistry, microarray and RNA-sequencing data. Cancer Cell Int 17. https:\/\/doi.org\/10.1186\/S12935-017-0455-1","DOI":"10.1186\/S12935-017-0455-1"},{"key":"7982_CR30","doi-asserted-by":"publisher","unstructured":"Lin C-Y, Yu C-J, Liu C-Y, Chao T-C, Huang C-C, Tseng L-M, Lai J-I (2023) Abstract P2-26-14: CDK4\/6 inhibitors modulate the ubiquitin\u2013proteasome pathway in ER+ breast cancer by downregulation of UBE2C\/S\/T. Cancer Res 83:P2-26-14 https:\/\/doi.org\/10.1158\/1538-7445.SABCS22-P2-26-14.","DOI":"10.1158\/1538-7445.SABCS22-P2-26-14"},{"issue":"9 31","key":"7982_CR31","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1007\/s12032-014-0180-8","volume":"31","author":"F Li","year":"2014","unstructured":"Li F, Zou Z, Suo N, Zhang Z, Wan F, Zhong G, Qu Y, Ntaka KS, Tian H (2014) CCL21\/CCR7 axis activating chemotaxis accompanied with epithelial\u2013mesenchymal transition in human breast carcinoma. Med Oncol 2014 31(9 31):180\u2013. https:\/\/doi.org\/10.1007\/s12032-014-0180-8","journal-title":"Med Oncol 2014"},{"key":"7982_CR32","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1126\/science.1185837","volume":"328","author":"JD Shields","year":"2010","unstructured":"Shields JD, Kourtis IC, Tomei AA, Roberts JM, Swartz MA (2010) Induction of lymphoidlike stroma and immune escape by tumors that express the chemokine CCL21. Science 328:749\u2013752. https:\/\/doi.org\/10.1126\/science.1185837","journal-title":"Science"},{"key":"7982_CR33","doi-asserted-by":"publisher","unstructured":"Li H, Yang P, Wang JH, Zhang J, Ma Q, Jiang Y, Wu Y, Han T, Xiang D (2022) HLF regulates ferroptosis, development and chemoresistance of triple-negative breast cancer by activating tumor cell-macrophage crosstalk. J Hematol Oncol 15. https:\/\/doi.org\/10.1186\/s13045-021-01223-x","DOI":"10.1186\/s13045-021-01223-x"},{"key":"7982_CR34","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1084\/jem.20181827","volume":"216","author":"NM Aiello","year":"2019","unstructured":"Aiello NM, Kang Y (2019) Context-dependent EMT programs in cancer metastasis. J Exp Med 216:1016\u20131026. https:\/\/doi.org\/10.1084\/jem.20181827","journal-title":"J Exp Med"},{"key":"7982_CR35","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.cell.2016.06.028","volume":"166","author":"MA Nieto","year":"2016","unstructured":"Nieto MA, Huang RYYJ, Jackson RAA, Thiery JPP (2016) EMT: 2016. Cell 166:21\u201345. https:\/\/doi.org\/10.1016\/j.cell.2016.06.028","journal-title":"Cell"},{"key":"7982_CR36","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1042\/BST20221124","volume":"51","author":"JM Derham","year":"2023","unstructured":"Derham JM, Kalsotra A (2023) The discovery, function, and regulation of epithelial splicing regulatory proteins (ESRP) 1 and 2. Biochem Soc Trans 51:1097\u20131109. https:\/\/doi.org\/10.1042\/BST20221124","journal-title":"Biochem Soc Trans"},{"key":"7982_CR37","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.1096\/fj.12-222042","volume":"27","author":"E Holmquist","year":"2013","unstructured":"Holmquist E, Okroj M, Nodin B, Jirstr\u00f6m K, Blom AM (2013) Sushi domain-containing protein 4 (SUSD4) inhibits complement by disrupting the formation of the classical C3 convertase. FASEB J 27:2355\u20132366. https:\/\/doi.org\/10.1096\/fj.12-222042","journal-title":"FASEB J"},{"key":"7982_CR38","doi-asserted-by":"publisher","unstructured":"Papadakos KS, Ekstr\u00f6m A, Slipek P, Skourti E, Reid S, Pietras K, Blom AM (2022) Sushi domain-containing protein 4 binds to epithelial growth factor receptor and initiates autophagy in an EGFR phosphorylation independent manner. J Exp Clin Cancer Res 41. https:\/\/doi.org\/10.1186\/s13046-022-02565-1","DOI":"10.1186\/s13046-022-02565-1"},{"key":"7982_CR39","doi-asserted-by":"publisher","unstructured":"Englund E, Reitsma B, King BC, Escudero-Esparza A, Owen S, Orimo A, Okroj M, Anagnostaki L, Jiang WG, Jirstr\u00f6m K, Blom AM (2015) The human complement inhibitor Sushi Domain-Containing Protein 4 (SUSD4) expression in tumor cells and infiltrating T cells is associated with better prognosis of breast cancer patients. BMC Cancer 15. https:\/\/doi.org\/10.1186\/s12885-015-1734-7","DOI":"10.1186\/s12885-015-1734-7"},{"key":"7982_CR40","doi-asserted-by":"publisher","unstructured":"Lee S, Toft NJ, Axelsen TV, Espejo MS, Pedersen TM, Mele M, Pedersen HL, Balling E, Johansen T, Burton M, Thomassen M, Vahl P, Christiansen P, Boedtkjer E (2023) Carbonic anhydrases reduce the acidity of the tumor microenvironment, promote immune infiltration, decelerate tumor growth, and improve survival in ErbB2\/HER2-enriched breast cancer. Breast Cancer Res 25. https:\/\/doi.org\/10.1186\/s13058-023-01644-1","DOI":"10.1186\/s13058-023-01644-1"},{"key":"7982_CR41","doi-asserted-by":"publisher","unstructured":"Porras L, Gorse F, Thiombane NK, Gaboury L, Mader S (2022) CAXII Is a Surrogate marker for luminal breast tumors regulated by ER and GATA3. Cancers (Basel) 14. https:\/\/doi.org\/10.3390\/cancers14215453","DOI":"10.3390\/cancers14215453"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-026-07982-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10549-026-07982-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-026-07982-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T08:30:07Z","timestamp":1784017807000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10549-026-07982-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,8]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["7982"],"URL":"https:\/\/doi.org\/10.1007\/s10549-026-07982-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7347995\/v1","asserted-by":"object"}]},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,8]]},"assertion":[{"value":"11 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have the following paid financial relationships with the funder: Receive research funding from funder: Nina D\u2019Abreo and Douglas Marks Employed and have stock ownership in funding company: Josien Haan, Nicole Chmielewski-Stivers, Andrea Menicucci, and William Audeh.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"30"}}